MENLO PARK, CA, MedaSystems, developer of the only purpose-built pharma-physician network to provide patients with access to pre-approval medicine*, today announced the completion of a seed funding round.
Participants in the round include a mix of strategic angel and health tech venture investors, with prior track records of founding and funding successful SaaS health companies, including Young Sohn, a founder of Veeva Systems, Vlocity, and Nomadic Systems; nina.capital, a specialist healthtech venture capital fund based in Barcelona; and members of the management team.
MedaSystems provides Clinical Request Management software for biopharma companies. MedaSystems' software platform streamlines the handling of requests for experimental therapies from healthcare providers. Their secure, GxP compliant application provides support for Expanded Access, Post-Trial Access and Investigator-Initiated Studies.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.